Guizhou Bailing Group Pharmaceutical Co.,Ltd.’s Net Profit Rose 5.7% in First Quarter of 2022

Guizhou Bailing Group Pharmaceutical Co.,Ltd. (贵州百灵企业集团制药股份有限公司) (002424.SZ) reported a net profit of 65.4 million yuan in the first quarter of 2022, up 5.7% year-on-year.

Meanwhile, the company posted 738.7 million yuan in revenue, down 1.9% year-on-year.

At the end of the reporting period, it had 6.4 billion yuan in total assets and 2.4 billion yuan in total liabilities, with a liability-to-asset ratio of 37.4%.